 |
|
|
| |
Ombitasvir/Paritaprevir/Ritonavir With Ribavirin Achieves High Sustained Virologic Response (SVR) Rates in Egypti an Adults With Chronic HCV Genotype 4 Infection (AGATE-II)
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Imam Waked1, Gamal Shiha2, Roula B Qaqish3, Gamal Esmat4, Ayman Yosry4, Wahid Doss5, Mohamed Hassany5, Reham Soliman2, Mohammad A Mohey4, Naglaa Allam1, Naglaa Zayed4, Carolyn Setze3, Rebecca Redman3, Niloufar Mobashery3
1Nati onal Liver Insti tute, Menoufi ya, Egypt; 2Egypti an Liver Research Institute And Hospital (ELRIAH), Dakahliah, Egypt; 3AbbVie Inc., North Chicago, Illinois, United States; 4Cairo University, Cairo, Egypt; 5National Hepatology & Tropical Medicine Research Institute, Cairo, Egypt
|
| |
|
|
|
|
|
